ArticleFrontiers in oncology2025
Case Report: Type A invasive thymoma with renal metastasis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atypical type A thymoma: a narrative review of a distinct and progressive variant of low-risk thymoma.Mediastinum (Hong Kong, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thymomas are rare malignancies originating from the epithelial cells of the thymus, typically presenting in the anterior mediastinum. Despite their indolent nature and slow growth, thymomas have the potential to metastasize to various organs, including the lungs, bones, and liver. However, renal metastasis is exceedingly rare. This case reported the details a 65-year-old male diagnosed with invasive thymoma (Type A, Masaoka stage IV) with renal metastasis seven years after the initial diagnosis. The patient underwent laparoscopic-assisted radical nephrectomy, followed by chemotherapy. The case demonstrated the potential for long-term survival among patients with advanced stages of thymoma when managed with a multidisciplinary approach, and underscored the need for monitoring extrathoracic metastases during the follow-up of patients with thymomas, thereby improving early detection and survival of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.